As a pan-microglial marker [51], the increased amount of Iba1 positivity in COVID points to heightened microgliosis and immune activation as key characteristics of systemic-CNS immune communication, both of which have been previously demonstrated to occur in humans with AD and models of the disease [15, 84, 85]. This evidence concerns the gene AIF1 and Alzheimer disease.